Dtsch Med Wochenschr 2006; 131(36): 1945-1950
DOI: 10.1055/s-2006-949192
Aktuelle Diagnostik & Therapie | Review article
Gastroenterologie, Chirurgie
© Georg Thieme Verlag KG Stuttgart · New York

Interdisziplinäre Behandlung des Rektumkarzinoms

Multidisciplinary treatment of rectal cancerA. Geier1 , H. Deppe2 , S. Willis3 , R. Holy4 , C. Trautwein1 , C. Gartung2
  • 1Medizinische Klinik III, Universitätsklinikum, Rheinisch-Westfälische Technische Hochschule Aachen
  • 2Zentrm für Innere Medizin, Schwerpunkt Gastroenterologie, Hepatologie und Infektionskrankheiten, Klinikum Minden
  • 3Chirurgische Klinik, Universitätsklinikum, Rheinisch-Westfälische Technische Hochschule Aachen
  • 4Klinik für Strahlentherapie, Universitätsklinikum, Rheinisch-Westfälische Technische Hochschule Aachen
Further Information

Publication History

eingereicht: 23.5.2006

akzeptiert: 8.8.2006

Publication Date:
07 September 2006 (online)

Literatur

  • 1 Adam R, Pascal G, Castaing D. et al . Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?.  Ann Surg. 2004;  240 1052-1061
  • 2 Andre N, Schmiegel W. Chemoradiotherapy for colorectal cancer.  Gut. 2005;  54 1194-1202
  • 3 Bujko K, Nowacki M P, Nasierowska-Guttmejer A. et al . Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.  Radiother Oncol. 2004;  72 15-24
  • 4 Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.  JAMA. 2000;  284 1008-1015
  • 5 Colorectal Cancer Collaborative Group . Surgery for colorectal cancer in elderly patients: a systematic review.  Lancet. 2000;  356 968-974
  • 6 Cunningham D, Humblet Y, Siena S. et al . Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.  N Engl J Med. 2004;  351 337-345
  • 7 de Gramont A, Figer A, Seymour M. et al . Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.  J Clin Oncol. 2000;  18 2938-2947
  • 8 Douillard J Y, Cunningham D, Roth A D. et al . Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.  Lancet. 2000;  355 1041-1047
  • 9 Fernandez F G, Ritter J, Goodwin J W, Linehan D C, Hawkins W G, Strasberg S M. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.  J Am Coll Surg. 2005;  200 845-853
  • 10 Giacchetti S, Perpoint B, Zidani R. et al . Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.  J Clin Oncol. 2000;  18 136-147
  • 11 Goldberg R M, Sargent D J, Morton R F. et al . A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.  J Clin Oncol. 2004;  22 23-30
  • 12 Grothey A, Sargent D, Goldberg R M, Schmoll H J. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.  J Clin Oncol. 2004;  22 1209-1214
  • 13 Hurwitz H, Fehrenbacher L, Novotny W. et al . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.  N Engl J Med. 2004;  350 2335-2342
  • 14 Kapiteijn E, Marijnen C A, Nagtegaal I D. et al. Dutch Colorectal Cancer Group . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.  N Engl J Med. 2001;  345 638-646
  • 15 Kehoe J, Khatri V P. Staging and prognosis of colon cancer.  Surg Oncol Clin N Am. 2006;  15 129-146
  • 16 MacFarlane J K, Ryall R D, Heald R J. Mesorectal excision for rectal cancer.  Lancet. 1993;  341 457-460
  • 17 Saltz L B, Cox J V, Blanke C. et al . Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.  N Engl J Med. 2000;  343 905-914
  • 18 Sauer R, Becker H, Hohenberger W. et al. German Rectal Cancer Study Group . Preoperative versus postoperative chemoradiotherapy for rectal cancer.  N Engl J Med. 2004;  351 1731-1740
  • 19 Schmiegel W, Pox C, Adler G. et al . S3-Leitlinienkonferenz „Kolorektales Karzinom” 2004.  Z Gastroenterol. 2004;  42 1129-1177
  • 20 Swedish Rectal Cancer Trial . Improved survival with preoperative radiotherapy in resectable rectal cancer.  N Engl J Med. 1997;  336 980-987
  • 21 Tournigand C, Andre T, Achille E. et al . FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.  J Clin Oncol. 2004;  22 229-237
  • 22 Willis S, Schumpelick V. Rekonstruktion nach Rektumresektion.  Chirurg. 2004;  75 13-20

Prof. Dr. med. Carsten Gartung

Klinikum Minden, Zentrum für Innere Medizin, Schwerpunkt Gastroenterologie, Hepatologie und Infektionskrankheiten

Friedrichstr. 17

32427 Minden

Phone: 0571/8013001

Fax: 0571/8013004

Email: carsten.gartung@klinikum-minden.de

    >